{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:52:27Z","timestamp":1781747547470,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370153"],"award-info":[{"award-number":["82370153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Technology Development Project of Jilin Province","award":["No. YDZJ202301ZYTS501"],"award-info":[{"award-number":["No. YDZJ202301ZYTS501"]}]},{"name":"Talent Reserve Program (TRP), the First Hospital of Jilin University","award":["No. JDYYCB-2023007"],"award-info":[{"award-number":["No. JDYYCB-2023007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10787-026-02272-9","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:24:29Z","timestamp":1779276269000},"page":"4165-4181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Daphnetin prevents acute graft-versus-host disease by suppressing donor T cell expansion and function"],"prefix":"10.1007","volume":"34","author":[{"given":"Zhi-Feng","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Xue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2272_CR1","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","volume":"20","author":"JT Barata","year":"2019","unstructured":"Barata JT, Durum SK, Seddon B (2019) Flip the coin: IL-7 and IL-7R in health and disease. Nat Immunol 20:1584\u20131593","journal-title":"Nat Immunol"},{"key":"2272_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-134","volume":"11","author":"CA B\u00e4UERLEIN","year":"2013","unstructured":"B\u00e4UERLEIN CA, Riedel SS, Baker J, Brede C, Garrote AL, Chopra M, Ritz M, Beilhack GF, Schulz S, Zeiser R, Schlegel PG, Einsele H, Negrin RS, Beilhack A (2013) A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model. BMC Med 11:134","journal-title":"BMC Med"},{"key":"2272_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2005-02-0509","volume":"106","author":"A Beilhack","year":"2005","unstructured":"Beilhack A, Schulz S, Baker J, Beilhack GF, Wieland CB, Herman EI, Baker EM, Cao YA, Contag CH, Negrin RS (2005) In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 106:1113\u20131122","journal-title":"Blood"},{"key":"2272_CR4","doi-asserted-by":"crossref","unstructured":"Biernacki, M. A., Sheth, V. S. & Bleakley, M. 2020. T cell optimization for graft-versus-leukemia responses. JCI Insight, 5.","DOI":"10.1172\/jci.insight.134939"},{"key":"2272_CR5","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1182\/blood.V92.10.3949","volume":"92","author":"BR Blazar","year":"1998","unstructured":"Blazar BR, Taylor PA, Mcelmurry R, Tian L, Panoskaltsis-Mortari A, Lam S, Lees C, Waldschmidt T, Vallera DA (1998) Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer. Blood 92:3949\u20133959","journal-title":"Blood"},{"key":"2272_CR6","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","volume":"388","author":"J Bola\u00f1os-meade","year":"2023","unstructured":"Bola\u00f1os-meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, Elmariah H, Rezvani AR, Gooptu M, Larkin KT, Shaffer BC, El Jurdi N, Loren AW, Solh M, Hall AC, Alousi AM, Jamy OH, Perales MA, Yao JM, Applegate K, Bhatt AS, Kean LS, Efebera YA, Reshef R, Clark W, Difronzo NL, Leifer E, Horowitz MM, Jones RJ, Holtan SG (2023) Post-transplantation Cyclophosphamide-based graft-versus-host disease prophylaxis. N Engl J Med 388:2338\u20132348","journal-title":"N Engl J Med"},{"key":"2272_CR7","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1182\/blood.2021011867","volume":"138","author":"R Chakraverty","year":"2021","unstructured":"Chakraverty R, Teshima T (2021) Graft-versus-host disease: a disorder of tissue regeneration and repair. Blood 138:1657\u20131665","journal-title":"Blood"},{"key":"2272_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/2040620720948743","volume":"11","author":"J Chen","year":"2020","unstructured":"Chen J, Wang H, Zhou J, Feng S (2020) Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation. Ther Adv Hematol 11:2040620720948743","journal-title":"Ther Adv Hematol"},{"key":"2272_CR9","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1182\/blood.V91.9.3315","volume":"91","author":"BR Dey","year":"1998","unstructured":"Dey BR, Yang YG, Szot GL, Pearson DA, Sykes M (1998) Interleukin-12 inhibits graft-versus-host disease through an Fas-mediated mechanism associated with alterations in donor T-cell activation and expansion. Blood 91:3315\u20133322","journal-title":"Blood"},{"key":"2272_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jaccao.2021.02.011","volume":"3","author":"R Dul\u00e9ry","year":"2021","unstructured":"Dul\u00e9ry R, Mohty R, Labopin M, Sestili S, Malard F, Brissot E, Battipaglia G, M\u00e9diavilla C, Banet A, VAN DE Wyngaert Z, Paviglianiti A, Belhocine R, Isnard F, Lapusan S, Adaeva R, Vekhoff A, Ledraa T, Legrand O, Cohen A, Bonnin A, Ederhy S, Mohty M (2021) Early cardiac toxicity associated with post-transplant Cyclophosphamide in allogeneic stem cell transplantation. JACC CardioOncol 3:250\u2013259","journal-title":"JACC CardioOncol"},{"key":"2272_CR11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","volume":"6","author":"A Emadi","year":"2009","unstructured":"Emadi A, Jones RJ, Brodsky RA (2009) Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 6:638\u2013647","journal-title":"Nat Rev Clin Oncol"},{"key":"2272_CR12","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-aguilar, L. M., vico-barranco, I., Arbulo-Echevarria, M. M. & Aguado, E. 2023. A Story of Kinases and Adaptors: The Role of Lck, ZAP-70 and LAT in Switch Panel Governing T-Cell Development and Activation. Biology (Basel), 12.","DOI":"10.3390\/biology12091163"},{"key":"2272_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jaci.2024.08.021","volume":"155","author":"AF Freeman","year":"2025","unstructured":"Freeman AF, Gonzalez CE, Yates B, Cole K, Little L, Flannelly E, Steinberg SM, Mo G, Piette N, Hughes TE, Cuellar-Rodriguez J, Gea-Banacloche J, Heller T, Hammoud DA, Holland SM, Kong HH, Young FD, Jing H, Kayaoglu B, Su HC, Pai SY, Hickstein DD, Shah NN (2025) Hematopoietic cell transplantation for DOCK8 deficiency: results from a prospective clinical trial. J Allergy Clin Immunol 155:176\u2013187","journal-title":"J Allergy Clin Immunol"},{"key":"2272_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-018-0020-8","volume":"18","author":"G Gaud","year":"2018","unstructured":"Gaud G, Lesourne R, Love PE (2018) Regulatory mechanisms in T cell receptor signalling. Nat Rev Immunol 18:485\u2013497","journal-title":"Nat Rev Immunol"},{"key":"2272_CR15","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1182\/blood.2019000952","volume":"136","author":"GR Hill","year":"2020","unstructured":"Hill GR, Koyama M (2020) Cytokines and costimulation in acute graft-versus-host disease. Blood 136:418\u2013428","journal-title":"Blood"},{"issue":"1","key":"2272_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1172\/JCI3132","volume":"102","author":"GR Hill","year":"1998","unstructured":"Hill GR, Cooke KR, Teshima T, Crawford JM, Keith JC, Brinson YS, Ferrara JL (1998) Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J Clin Invest 102(1):115\u2013123","journal-title":"J Clin Invest"},{"key":"2272_CR17","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1182\/blood.2023020073","volume":"142","author":"O Jamy","year":"2023","unstructured":"Jamy O, Zeiser R, Chen YB (2023) Novel developments in the prophylaxis and treatment of acute GVHD. Blood 142:1037\u20131046","journal-title":"Blood"},{"key":"2272_CR18","doi-asserted-by":"publisher","first-page":"9308","DOI":"10.1096\/fj.201802659RR","volume":"33","author":"J Ji","year":"2019","unstructured":"Ji J, Ge X, Chen Y, Zhu B, Wu Q, Zhang J, Shan J, Cheng H, Shi L (2019) Daphnetin ameliorates experimental colitis by modulating microbiota composition and T(reg)\/T(h)17 balance. FASEB J 33:9308\u20139322","journal-title":"FASEB J"},{"key":"2272_CR19","first-page":"640","volume":"110","author":"MN Kerbauy","year":"2025","unstructured":"Kerbauy MN, Rocha FA, Arcuri LJ, Cunegundes PS, Kerbauy LN, Machado CM, Ribeiro AAF, Banerjee PP, Marti LC, Hamerschlak N (2025) Immune reconstitution dynamics after unrelated allogeneic transplantation with post-transplant cyclophosphamide compared to classical immunosuppression with anti-thymocyte globulin: a prospective cohort study. Haematologica 110:640\u2013650","journal-title":"Haematologica"},{"key":"2272_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13287-020-01768-7","volume":"11","author":"JY Lim","year":"2020","unstructured":"Lim JY, Ryu DB, Kim TW, Lee SE, Park G, Yoon HK, Min CK (2020) CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model. Stem Cell Res Ther 11:254","journal-title":"Stem Cell Res Ther"},{"key":"2272_CR21","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.24976\/Discov.Med.202436190.199","volume":"36","author":"SG Long","year":"2024","unstructured":"Long SG, Zhang ZQ, Tan J (2024) Daphnetin modulates immune balance and enhances pregnancy viability in a mouse model of unexplained recurrent abortion. Discov Med 36:2175\u20132181","journal-title":"Discov Med"},{"key":"2272_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41375-020-0863-4","volume":"35","author":"F Lorentino","year":"2021","unstructured":"Lorentino F, Labopin M, Ciceri F, Vago L, Fleischhauer K, Afanasyev B, KR\u00f6GER N, Cornelissen JJ, Lovira M, Meijer E, Vitek A, Elmaagacli A, Blaise D, Ruggeri A, Chabannon C, Nagler A, Mohty M (2021) Post-transplantation Cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9\/10 or 10\/10 HLA-matched unrelated donors for acute leukemia. Leukemia 35:585\u2013594","journal-title":"Leukemia"},{"key":"2272_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1053\/j.seminoncol.2012.09.005","volume":"39","author":"L Luznik","year":"2012","unstructured":"Luznik L, O\u2019donnell PV, Fuchs EJ (2012) Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Semin Oncol 39:683\u2013693","journal-title":"Semin Oncol"},{"key":"2272_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.exphem.2023.04.003","volume":"123","author":"Y Makuuchi","year":"2023","unstructured":"Makuuchi Y, Nakashima Y, Nishimoto M, Koh H, Hino M, Nakamae H (2023) Posttransplant cyclophosphamide contributes to the impairment of the graft-versus-leukemia effect and the amelioration of graft-versus-host disease with the suppression of alloreactive T cells in a murine stem cell transplant model. Exp Hematol 123:56\u201365","journal-title":"Exp Hematol"},{"key":"2272_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/10428190400005320","volume":"46","author":"JK Mangan","year":"2005","unstructured":"Mangan JK, Reddy EP (2005) Activation of the Jak3 pathway and myeloid differentiation. Leuk Lymphoma 46:21\u201327","journal-title":"Leuk Lymphoma"},{"key":"2272_CR26","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1182\/blood.2021013054","volume":"139","author":"SR Mccurdy","year":"2022","unstructured":"Mccurdy SR, Radojcic V, Tsai HL, Vulic A, Thompson E, Ivcevic S, Kanakry CG, Powell JD, Lohman B, Adom D, Paczesny S, Cooke KR, Jones RJ, Varadhan R, Symons HJ, Luznik L (2022) Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning. Blood 139:608\u2013623","journal-title":"Blood"},{"key":"2272_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41409-024-02474-1","volume":"60","author":"T Meyer","year":"2025","unstructured":"Meyer T, Maas-Bauer K, W\u00e4SCH R, Duyster J, Zeiser R, Finke J, Wehr C (2025) Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation Cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis. Bone Marrow Transplant 60:286\u2013296","journal-title":"Bone Marrow Transplant"},{"key":"2272_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101092","volume":"62","author":"M Mikulska","year":"2023","unstructured":"Mikulska M, Bartalucci C, Raiola AM, Oltolini C (2023) Does PTCY increase the risk of infections? Blood Rev 62:101092","journal-title":"Blood Rev"},{"key":"2272_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.101034","volume":"62","author":"PV O'Donnell","year":"2023","unstructured":"O\u2019Donnell PV, Jones RJ (2023) The development of post-transplant cyclophosphamide: half a century of translational team science. Blood Rev 62:101034","journal-title":"Blood Rev"},{"key":"2272_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176826","volume":"979","author":"JY Park","year":"2024","unstructured":"Park JY, Lee JW, Oh ES, Song YN, Kang MJ, Ryu HW, Kim DY, Oh SR, Lee J, Choi J, Kim N, Kim MO, Hong ST, Lee SU (2024) Daphnetin alleviates allergic airway inflammation by inhibiting T-cell activation and subsequent JAK\/STAT6 signaling. Eur J Pharmacol 979:176826","journal-title":"Eur J Pharmacol"},{"key":"2272_CR31","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","volume":"56","author":"JR Passweg","year":"2021","unstructured":"Passweg JR, Baldomero H, Chabannon C, Basak GW, DE LA C\u00e1mara R, Corbacioglu S, Dolstra H, Duarte R, Glass B, Greco R, Lankester AC, Mohty M, PEFFAULT DE Latour R, Snowden JA, Yakoub-Agha I, KR\u00f6GER N (2021) Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplant 56:1651\u20131664","journal-title":"Bone Marrow Transplant"},{"key":"2272_CR32","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/s41375-024-02225-7","volume":"38","author":"O Penack","year":"2024","unstructured":"Penack O, Abouqateb M, Peczynski C, Boreland W, KR\u00f6GER N, Stelljes M, Gedde-Dahl T, Blau IW, Schroeder T, Salmenniemi U, Kulagin A, PEFFAULT DE Latour R, Mielke S, Zeiser R, Moiseev I, Schoemans H, Koenecke C, Peric Z (2024a) ATG or post-transplant Cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation? Leukemia 38:1156\u20131163","journal-title":"Leukemia"},{"key":"2272_CR33","doi-asserted-by":"crossref","unstructured":"Penack, O., Marchetti, M., Aljurf, M., Arat, M., Bonifazi, F., Duarte, R. F., Giebel, S., Greinix, H., Hazenberg, M. D., kr\u00f6ger, N., Mielke, S., Mohty, M., Nagler, A., Passweg, J., Patriarca, F., Ruutu, T., Schoemans, H., Solano, C., Vrhovac, R., Wolff, D., Zeiser, R., Sureda, A. & Peric, Z. 2024b. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol, 11, e147-e159.","DOI":"10.1016\/S2352-3026(23)00342-3"},{"key":"2272_CR34","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Valencia, A. I., Cascos, E., Carbonell-Ordeig, S., Charry, P., G\u00f3mez-Hernando, M., Rodr\u00edguez-Lobato, L. G., Su\u00e1rez-Lled\u00f3, M., Mart\u00ednez-Cibrian, N., Antelo, M. G., Solano, M. T., Arcarons, J., Nomdedeu, M., Cid, J., Lozano, M., D\u00edaz-Ricart, M., Rosi\u00f1ol, L., Esteve, J., Urbano-Ispizua, \u00c1., Carreras, E., Mart\u00ednez, C., Fern\u00e1ndez-Avil\u00e9s, F., Rovira, M. & Salas, M. Q. 2023. Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant. Blood Adv, 7, 2018\u20132031.","DOI":"10.1182\/bloodadvances.2022008792"},{"key":"2272_CR35","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1182\/blood-2006-12-061408","volume":"110","author":"KP Piper","year":"2007","unstructured":"Piper KP, Horlock C, Curnow SJ, Arrazi J, Nicholls S, Mahendra P, Craddock C, Moss PA (2007) CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation. Blood 110:3827\u20133832","journal-title":"Blood"},{"key":"2272_CR36","doi-asserted-by":"crossref","unstructured":"Samuels, D. T., Yao, J. M., Samara, Y., Yang, D., Mokhtari, S., Tiemann, K., Otoukesh, S., Arslan, S., Pourhassan, H., WU, S., Blackmon, A., Agrawal, V., Amanam, I., Ali, H., Salhotra, A., Aldoss, I., Ball, B., Koller, P., Aribi, A., Sandhu, K., Pullarkat, V., Artz, A., Smith, E., Stewart, F., Becker, P., Stein, A., Marcucci, G., Forman, S. J., Nakamura, R. & AL Malki, M. M. 2025. Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis. Front Immunol, 16, 1543099.","DOI":"10.3389\/fimmu.2025.1543099"},{"key":"2272_CR37","doi-asserted-by":"publisher","first-page":"588","DOI":"10.4049\/jimmunol.170.1.588","volume":"170","author":"M Sasaki","year":"2003","unstructured":"Sasaki M, Hasegawa H, Kohno M, Inoue A, Ito MR, Fujita S (2003) Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice. J Immunol 170:588\u2013596","journal-title":"J Immunol"},{"key":"2272_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.55782\/ane-2022-026","volume":"82","author":"A Soltanmohammadi","year":"2022","unstructured":"Soltanmohammadi A, Tavaf MJ, Zargarani S, Yazdanpanah E, Sadighi-Moghaddam B, Yousefi B, Sameni HR, Haghmorad D (2022) Daphnetin alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating Th2 and regulatory T cells. Acta Neurobiol Exp (Wars) 82:273\u2013283","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"2272_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096502","volume":"9","author":"B Song","year":"2014","unstructured":"Song B, Wang Z, Liu Y, Xu S, Huang G, Xiong Y, Zhang S, Xu L, Deng X, Guan S (2014) Immunosuppressive activity of daphnetin, one of coumarin derivatives, is mediated through suppression of NF-\u03baB and NFAT signaling pathways in mouse T cells. PLoS ONE 9:e96502","journal-title":"PLoS ONE"},{"key":"2272_CR40","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1182\/blood-2013-12-543736","volume":"123","author":"S Spoerl","year":"2014","unstructured":"Spoerl S, Mathew NR, Bscheider M, Schmitt-Graeff A, Chen S, Mueller T, Verbeek M, Fischer J, Otten V, Schmickl M, Maas-Bauer K, Finke J, Peschel C, Duyster J, Poeck H, Zeiser R, von Bubnoff N (2014) Activity of therapeutic JAK 1\/2 blockade in graft-versus-host disease. Blood 123:3832\u20133842","journal-title":"Blood"},{"key":"2272_CR41","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1038\/s41423-021-00775-9","volume":"18","author":"L Su","year":"2021","unstructured":"Su L, Fang MH, Zou J, Gao SJ, Gu XY, Meng XD, Wang X, Hu Z, Yang YG (2021) Posttransplant blockade of CXCR4 improves leukemia complete remission rates and donor stem cell engraftment without aggravating GVHD. Cell Mol Immunol 18:2541\u20132553","journal-title":"Cell Mol Immunol"},{"key":"2272_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155901","volume":"132","author":"L Su","year":"2024","unstructured":"Su L, Wei ZF, Pi CC, Qin TX, Song F, Zhang YW, Gao SJ (2024) Icariin protects against acute graft-versus-host disease while preserving graft-versus-leukemia activity after allogeneic hematopoietic stem cell transplantation. Phytomedicine 132:155901","journal-title":"Phytomedicine"},{"key":"2272_CR43","doi-asserted-by":"publisher","first-page":"1296663","DOI":"10.3389\/fimmu.2023.1296663","volume":"14","author":"T Teshima","year":"2023","unstructured":"Teshima T, Hashimoto D (2023) Separation of GVL from GVHD -location, location, location. Front Immunol 14:1296663","journal-title":"Front Immunol"},{"key":"2272_CR44","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.4049\/jimmunol.155.11.5220","volume":"155","author":"PJ Tortolani","year":"1995","unstructured":"Tortolani PJ, Lal BK, Riva A, Johnston JA, Chen YQ, Reaman GH, Beckwith M, Longo D, Ortaldo JR, Bhatia K, Mcgrath I, Kehrl J, Tuscano J, Mcvicar DW, O\u2019shea JJ (1995) Regulation of JAK3 expression and activation in human B cells and B cell malignancies. J Immunol 155:5220\u20135226","journal-title":"J Immunol"},{"key":"2272_CR45","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1016\/j.immuni.2023.11.010","volume":"56","author":"YL Tsai","year":"2023","unstructured":"Tsai YL, Arias-Badia M, Kadlecek TA, Lwin YM, Srinath A, Shah NH, Wang ZE, Barber D, Kuriyan J, Fong L, Weiss A (2023) TCR signaling promotes formation of an STS1-Cbl-b complex with pH-sensitive phosphatase activity that suppresses T cell function in acidic environments. Immunity 56:2682-2698.e9","journal-title":"Immunity"},{"key":"2272_CR46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/cdd.2016.155","volume":"24","author":"S Tuzlak","year":"2017","unstructured":"Tuzlak S, Schenk RL, Vasanthakumar A, Preston SP, Haschka MD, Zotos D, Kallies A, Strasser A, Villunger A, Herold MJ (2017) The BCL-2 pro-survival protein A1 is dispensable for T cell homeostasis on viral infection. Cell Death Differ 24:523\u2013533","journal-title":"Cell Death Differ"},{"key":"2272_CR47","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","volume":"13","author":"DA Vignali","year":"2012","unstructured":"Vignali DA, Kuchroo VK (2012) IL-12 family cytokines: immunological playmakers. Nat Immunol 13:722\u2013728","journal-title":"Nat Immunol"},{"key":"2272_CR48","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1172\/JCI124218","volume":"129","author":"LP Wachsmuth","year":"2019","unstructured":"Wachsmuth LP, Patterson MT, Eckhaus MA, Venzon DJ, Gress RE, Kanakry CG (2019) Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression. J Clin Invest 129:2357\u20132373","journal-title":"J Clin Invest"},{"key":"2272_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1407010","volume":"15","author":"Z Wei","year":"2024","unstructured":"Wei Z, Wei N, Su L, Gao S (2024) The molecular effects underlying the pharmacological activities of daphnetin. Front Pharmacol 15:1407010","journal-title":"Front Pharmacol"},{"key":"2272_CR50","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1021\/acs.jafc.2c02140","volume":"70","author":"L Yan","year":"2022","unstructured":"Yan L, Jin Y, Pan J, He X, Zhong S, Zhang R, Choi L, Su W, Chen J (2022) 7,8-Dihydroxycoumarin alleviates synaptic loss by activated PI3K-Akt-CREB-BDNF signaling in Alzheimer\u2019s disease model mice. J Agric Food Chem 70:7130\u20137138","journal-title":"J Agric Food Chem"},{"key":"2272_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41417-023-00710-2","volume":"31","author":"D Yan","year":"2024","unstructured":"Yan D, Li G, Yuan Y, Li H, Cao H, Dai Y, Li Y, Zhang Z, Li F, Fang Y, Gao Q (2024) SOCS3 inhibiting JAK-STAT pathway enhances oncolytic adenovirus efficacy by potentiating viral replication and T-cell activation. Cancer Gene Ther 31:397\u2013409","journal-title":"Cancer Gene Ther"},{"key":"2272_CR52","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1182\/blood.V90.11.4651","volume":"90","author":"YG Yang","year":"1997","unstructured":"Yang YG, Sergio JJ, Pearson DA, Szot GL, Shimizu A, Sykes M (1997) Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood 90:4651\u20134660","journal-title":"Blood"},{"key":"2272_CR53","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1006\/bbrc.1999.0958","volume":"260","author":"EB Yang","year":"1999","unstructured":"Yang EB, Zhao YN, Zhang K, Mack P (1999) Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor. Biochem Biophys Res Commun 260:682\u2013685","journal-title":"Biochem Biophys Res Commun"},{"key":"2272_CR54","doi-asserted-by":"crossref","unstructured":"Yang, T., Hu, Y., Yan, Y., Zhou, W., Chen, G., Zeng, X. & Cao, Y. 2022. Characterization and Evaluation of Antioxidant and Anti-Inflammatory Activities of Flavonoids from the Fruits of Lycium barbarum. Foods, 11.","DOI":"10.3390\/foods11030306"},{"key":"2272_CR55","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR (2017) Acute Graft-versus-Host Disease - biologic process, prevention, and therapy. N Engl J Med 377:2167\u20132179","journal-title":"N Engl J Med"},{"key":"2272_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","volume":"14","author":"XH Zhang","year":"2021","unstructured":"Zhang XH, Chen J, Han MZ, Huang H, Jiang EL, Jiang M, Lai YR, Liu DH, Liu QF, Liu T, Ren HY, Song YP, Sun ZM, Tang XW, Wang JM, Wu DP, Xu LP, Zhang X, Zhou DB, Huang XJ (2021) The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol 14:145","journal-title":"J Hematol Oncol"},{"key":"2272_CR57","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-022-01287-3","volume":"15","author":"C Zhao","year":"2022","unstructured":"Zhao C, Bartock M, Jia B, Shah N, Claxton DF, Wirk B, Rakszawski KL, Nickolich MS, Naik SG, Rybka WB, Ehmann WCC, Hohl RJ, Valentin J, Bernas-Peterson M, Gerber EM, Zimmerman M, Mierski JA, Mineishi S, Zheng H (2022) Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant. J Hematol Oncol 15:64","journal-title":"J Hematol Oncol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02272-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02272-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02272-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:16:23Z","timestamp":1781745383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02272-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2272"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02272-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}